Medtronic Gatekeeper
This article was originally published in The Gray Sheet
Executive Summary
European acid reflux repair system market launch will commence in coming weeks, firm says May 20 after receiving CE mark authorization. U.S. feasibility trials are completed for the endoscopic delivery system/lower esophageal sphincter prostheses, which will target an estimated 375 mil. patients worldwide. Pivotal trials with 12-month follow up will begin this summer, Medtronic says...